Cardiovascular Systems (CSII) Earns Daily News Sentiment Rating of 0.06
Press coverage about Cardiovascular Systems (NASDAQ:CSII) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardiovascular Systems earned a media sentiment score of 0.06 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 47.6909965403129 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Cardiovascular Systems, Inc. (CSII) Receives New Coverage from Analysts at Raymond James Financial, Inc. (americanbankingnews.com)
- Cardiovascular Systems, Inc. (CSII) Earns Market Perform Rating from Analysts at Citigroup Inc. (americanbankingnews.com)
- Leerink Swann Equities Analysts Lower Earnings Estimates for Cardiovascular Systems, Inc. (CSII) (americanbankingnews.com)
- Consensus Buy Analysis: Cardiovascular Systems, Inc. (CSII) – Street Observer (press release) (streetobserver.com)
- Will Hurricanes Choke Cardiovascular (CSII) Q1 Performance? – Nasdaq (nasdaq.com)
Several research analysts have commented on the company. BidaskClub downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Raymond James Financial, Inc. assumed coverage on Cardiovascular Systems in a report on Friday. They set a “market perform” rating on the stock. Zacks Investment Research downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Citigroup Inc. assumed coverage on Cardiovascular Systems in a report on Thursday. They set a “market perform” rating on the stock. Finally, Bank of America Corporation downgraded Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 21st. Three analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $33.83.
Cardiovascular Systems (NASDAQ:CSII) opened at 27.52 on Friday. Cardiovascular Systems has a one year low of $21.29 and a one year high of $33.11. The stock’s market capitalization is $907.91 million. The stock has a 50 day moving average price of $29.97 and a 200-day moving average price of $30.14.
Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings data on Wednesday, August 2nd. The medical device company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.07. Cardiovascular Systems had a positive return on equity of 0.88% and a negative net margin of 0.87%. The business had revenue of $52.90 million for the quarter, compared to analyst estimates of $51.98 million. During the same quarter in the prior year, the company earned ($0.15) earnings per share. The company’s revenue was up 9.1% on a year-over-year basis.
In other news, Director Edward M. Brown sold 13,031 shares of the company’s stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $29.09, for a total transaction of $379,071.79. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Edward M. Brown sold 20,000 shares of the company’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $29.16, for a total value of $583,200.00. The disclosure for this sale can be found here. Insiders have sold 51,065 shares of company stock worth $1,514,031 in the last ninety days. Corporate insiders own 3.60% of the company’s stock.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.